-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on ArcBest, Lowers Price Target to $84

Benzinga·04/30/2025 16:54:11
Listen to the news
Goldman Sachs analyst Jordan Alliger maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $97 to $84.